Daniel, 57, had metastatic colorectal cancer . He had received several lines of chemotherapy and targeted therapy, but the latest CT scan showed clear progression. His oncologist explained that the standard options were almost exhausted.
Her daughter started searching the internet for clinical trials for colon cancer ; the amount of information was overwhelming and she didn’t know what was reliable. They came to Nexus Oncology through an acquaintance.
- Case review and molecular profile
- We analyzed all of their documentation, including a previous genomic panel that showed a rare mutation, and a recent liquid biopsy.
- With that information we define a very specific profile: type of mutation, number of previous lines, general condition and location of the disease.
- Search for clinical trials
- We identified several phase I/II trials in Spain and Europe that included drugs targeting its molecular alteration.
- We prioritized two studios that were geographically accessible and had realistic requirements for Daniel.
- Contact and coordination
- We shared the clinical summary with the clinical trials unit of a reference hospital.
- An assessment visit was arranged within a few weeks.
- His original oncologist was informed at all times and participated in the decision.
Daniel finally entered a combined targeted therapy trial . After several months of treatment, the tumor stabilized and some areas decreased in size.
“I knew a clinical trial wasn’t a guarantee, but feeling that there were still doors to open gave us back hope. What I appreciated most was that someone did that research for us and accompanied us every step of the way.”
Not all patients will find a suitable trial, and not all trials will work. But we can assure you that we will systematically and rigorously seek reasonable opportunities for each case.
